Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America

Lung-function decline is one of the possible mechanisms leading to Chronic Obstructive Pulmonary Disease (COPD). We analyzed data obtained from two population-based surveys of adults (n = 2026) conducted in the same individuals 5-9 years (y) after their baseline examination in three Latin-American c...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:PloS one Ročník 12; číslo 5; s. e0177032
Hlavní autori: Pérez-Padilla, Rogelio, Fernandez-Plata, Rosario, Montes de Oca, Maria, Lopez-Varela, Maria Victorina, Jardim, Jose R., Muiño, Adriana, Valdivia, Gonzalo, Menezes, Ana Maria B.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Public Library of Science 04.05.2017
Public Library of Science (PLoS)
Predmet:
ISSN:1932-6203, 1932-6203
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Lung-function decline is one of the possible mechanisms leading to Chronic Obstructive Pulmonary Disease (COPD). We analyzed data obtained from two population-based surveys of adults (n = 2026) conducted in the same individuals 5-9 years (y) after their baseline examination in three Latin-American cities. Post BronchoDilator (postBD) FEV1 decline in mL/y, as %predicted/y (%P/y) and % of baseline/y (%B/y) was calculated and the influence of age, gender, BMI, baseline lung function, BD response, exacerbations rate evaluated using multivariate models. Expressed in ml/y, the mean annual postBD FEV1 decline was 27 mL (0.22%P, 1.32%B) in patients with baseline COPD and 36 (0.14%P, 1.36%B) in those without. Faster decline (in mL/y) was associated with higher baseline lung function, with significant response to bronchodilators, older age and smoking at baseline, also in women with chronic cough and phlegm, or ≥2 respiratory exacerbations in the previous year, and in men with asthma. Lung function decline in a population-based cohort did not differ in obstructed and non-obstructed individuals, it was proportional to baseline FEV1, and was higher in smokers, elderly, and women with respiratory symptoms.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceptualization: AMM RPP.Data curation: AMM RFP RPP.Formal analysis: RFP RPP.Funding acquisition: AMM MLV JRJ GV.Investigation: AMM MLV JRJ GV MMO RPP.Methodology: AMM RPP RFP.Project administration: AMM MVL GV JRJ AM MMO.Resources: AMM MVL GV JRJ AM.Supervision: AMM RPP MMO GV JRJ MLV AM.Writing – original draft: RPP RFP AMM.Writing – review & editing: RPP AMM RFP JRJ GV MMO AM MLV.
Competing Interests: The study was sponsored by ALAT, Boehringer, GSK, and Novartis. This does not alter our adherence to PLOS ONE policies on sharing data and materials, in a public repository.
Membership of the PLATINO group is provided in the Acknowledgments
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0177032